People · Operator
Named in public records as an officer, director or promoter · active 2010–2017 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Compass Therapeutics LLC | — | Biotechnology | Series D+ | $132.6M | $900.7M | 2015 |
| Good Start Genetics, Inc. | — | Biotechnology | Series B | $28.2M | $396.9M | 2010 |
CARL J. GORDON at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside CARL J. GORDON on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carl Gordon | 2 | 24 |
| Ben Auspitz | 1 | 9 |
| Stephen Squinto | 1 | 8 |
| Gary Kurtzman | 1 | 8 |
| Errik Anderson | 1 | 8 |
| Philip J. Ferneau | 1 | 6 |
| Philip Ferneau | 1 | 6 |
| Lutz Giebel | 1 | 6 |
| Robert Carpenter | 1 | 5 |
| Thomas Schuetz | 1 | 4 |
| Marc Beer | 1 | 4 |
| Robert J. Carpenter | 1 | 3 |
| Don Hardison | 1 | 2 |
| Steve Tregay | 1 | 2 |
| Jonathan Sheller | 1 | 2 |
| Thomas J. Schuetz | 1 | 2 |
| Eric D. Boutin | 1 | 1 |
| Don J. Hardison | 1 | 1 |
| Paris J. Wallace | 1 | 1 |
| Schuetz Thomas | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.